JAK2 and myeloproliferative neoplasm: The classical BCR–ABL1 negative MPN ET, PV, and PMF are characterized by driver mutations in the genes JAK2, MPL, or CALR that lead to a ligand independent activation of JAK/STAT signaling [36].